Primenenie biologicheski aktivnoy dobavki "Urisan" k pishche pri mochekamennoy bolezni
- Authors: Dzeranov NK1, Konstantinova OV1, Nikonova LM1, Cherepanova EV1, Drozhzheva VV1
-
Affiliations:
- Issue: No 5 (2009)
- Pages: 12-
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277507
- ID: 277507
Cite item
Full Text
Abstract
Thirty three urolithiasis patients (13 males, 18 females aged 29-77 years, 2 children, duration of the disease 1-17 years) received food additive urisan in combined treatment of urolithiasis. Blood and urine biochemistry was studied by 11 parameters to evaluate renal function and lithogenesis before and after intake of urisan. Standard treatment was combined with intake of 2 capsules (1100 mg) of urisan twice a day at meal for 2-3 weeks. The data were processed statistically. It is shown that urisan contributes to intensification of renal filtration function, to reduction of hyperuricemia and urine pH, intensification of uric acid excretion, continuation of inflammation remission, attenuation of proteinurea in urolithiasis patients with exacerbation of chronic pyelonephritis.
References
- Лопаткин Н. А., Перепанова Т. С. (ред.). Рациональная фармакотерапия в урологии. М.: Литтерра; 2006.
- Тиктинский О. Л., Александров В. П. Мочекаменная болезнь. СПб.; 2000.
- Пытель Ю. А., Золотарев И. И. Уратный нефролитиаз. М.: Медицина; 1995.
- Park S. Medical management of urinary stone disease. Expert Opin. Pharmacother. 2007; 8: 1117-1125.
- Дзеранов Н. К., Константинова О. В., Бешлиев Д. А. и др. Роль фитотерапии в пред- и послеоперационном периоде у больных уролитиазом. Урология 2005; 2: 18-20.
- Павлов В. Н., Гаянов Р. А. Возможность применения биологически активной добавки "Пролит" в комплексном лечении нефролитиаза. Врач. сословие 2006; 5-6: 36-39.
- Машковский М. Д. Лекарственные средства. М.: Новая волна; 2002; т. 1.
Supplementary files
